BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 11347105)

  • 1. [4S [Scandinavian Simvastatin Survival Study]].
    Koizumi J; Yoshida I
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():410-5. PubMed ID: 11347105
    [No Abstract]   [Full Text] [Related]  

  • 2. [The 4-S study--a turning point in the cholesterol debate. Work Group Lipids and Atherosclerosis of the Swiss Society for Cardiology].
    Nigg C
    Praxis (Bern 1994); 1995 Dec; 84(51-52):1514-6. PubMed ID: 8571010
    [No Abstract]   [Full Text] [Related]  

  • 3. Profiling a landmark clinical trial: Scandinavian Simvastatin Survival Study.
    Guptha S
    Curr Opin Lipidol; 1995 Oct; 6(5):251-3. PubMed ID: 8520845
    [No Abstract]   [Full Text] [Related]  

  • 4. [Primary and secondary prevention of coronary disease by statins].
    Ferrières J
    Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):128-36. PubMed ID: 12555337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent developments in coronary heart disease prevention: the Scandinavian and west of Scotland studies.
    Elam MB; Cushman W; Applegate WB; Heimberg M
    Tenn Med; 1997 May; 90(5):189-92. PubMed ID: 9130876
    [No Abstract]   [Full Text] [Related]  

  • 6. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
    Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
    Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
    [No Abstract]   [Full Text] [Related]  

  • 7. Simvastatin for secondary prevention of all-cause mortality and major coronary events in patients with mild chronic renal insufficiency.
    Chonchol M; Cook T; Kjekshus J; Pedersen TR; Lindenfeld J
    Am J Kidney Dis; 2007 Mar; 49(3):373-82. PubMed ID: 17336698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Scandinavian Simvastatin Survival Study (4S): hasty conclusions].
    Ravnskov U
    Ugeskr Laeger; 1995 Apr; 157(15):2165-6. PubMed ID: 7652961
    [No Abstract]   [Full Text] [Related]  

  • 9. [Real results of The Scandinavian Simvastatin Survival Study (4S)].
    Ostergaard Kristensen B
    Ugeskr Laeger; 1995 Apr; 157(15):2164-5. PubMed ID: 7652960
    [No Abstract]   [Full Text] [Related]  

  • 10. [The Scandinavian Simvastatin Survival Study: the clinical consequences].
    Larsen ML
    Rev Esp Cardiol; 1995; 48 Suppl 5():39-42. PubMed ID: 7494939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overlap analysis of the West of Scotland coronary prevention study (WOSCOPS).
    Lim PO; Yee KM
    Circulation; 1999 Aug; 100(6):686. PubMed ID: 10441109
    [No Abstract]   [Full Text] [Related]  

  • 12. Safe use of ezetimibe plus simvastatin in high-risk vascular patients (with chronic kidney disease and PAD).
    Aalbers J
    Cardiovasc J Afr; 2011; 22(4):227-8. PubMed ID: 21881698
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of simvastatin or ezetimibe on tissue factor, von Willebrand's factor and C-reactive protein in patients with hypercholesterolaemia.
    Kostakou P; Kolovou G; Anagnostopoulou K; Theodoridis T; Galea V; Mihas C; Christopoulou-Cokkinou V; Cokkinos DV
    Arch Cardiovasc Dis; 2010 Jan; 103(1):26-32. PubMed ID: 20142117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On the current debate on lowering LDL cholesterol with ezetimibe].
    Breuer HW
    Dtsch Med Wochenschr; 2010 Nov; 135(44):2201; author reply 2202. PubMed ID: 20979008
    [No Abstract]   [Full Text] [Related]  

  • 15. [LIPID study [Long-term Intervention with Pravastatin in Ischaemic Disease study]].
    Homma Y
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():416-21. PubMed ID: 11347106
    [No Abstract]   [Full Text] [Related]  

  • 16. [For coronary disease patients is certain: the lower the LDL the better].
    MMW Fortschr Med; 2006 Jun; 148(24):6. PubMed ID: 16850797
    [No Abstract]   [Full Text] [Related]  

  • 17. LDL-Cholesterol is the King.
    Goumas GS
    Angiology; 2009; 60(3):387-8. PubMed ID: 19497926
    [No Abstract]   [Full Text] [Related]  

  • 18. [Substantiation of increasing doses of statins in clinical practice].
    Susekov AV
    Ter Arkh; 2001; 73(4):76-80. PubMed ID: 11494456
    [No Abstract]   [Full Text] [Related]  

  • 19. Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S).
    Strandberg TE; Pyörälä K; Cook TJ; Wilhelmsen L; Faergeman O; Thorgeirsson G; Pedersen TR; Kjekshus J;
    Lancet; 2004 Aug 28-Sep 3; 364(9436):771-7. PubMed ID: 15337403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypercholesterolemia. Is lipid-lowering worthwhile for older patients?
    Deedwania PC
    Geriatrics; 2000 May; 55(5):22-8. PubMed ID: 10826262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.